Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

20125,395 citationsJournal Articlebronze Open Access

Authors

Pieter van Hagen · Erasmus MC

Maarten C.C.M. Hulshof

J. Jan B. van Lanschot

Ewout W. Steyerberg

Mark I. van Berge Henegouwen

Bas P. L. Wijnhoven

Dick J. Richel

Grard A. P. Nieuwenhuijzen

Geke A.P. Hospers

Johannes J. Bonenkamp

Miguel A. Cuesta

Abstract

Preoperative chemoradiotherapy improved survival among patients with potentially curable esophageal or esophagogastric-junction cancer. The regimen was associated with acceptable adverse-event rates. (Funded by the Dutch Cancer Foundation [KWF Kankerbestrijding]; Netherlands Trial Register number, NTR487.).

Topics & Keywords

Esophageal Cancer Research and Treatment Gastric Cancer Management and Outcomes Esophageal and GI Pathology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 366, Issue 22, pp. 2074-2084

DOI: 10.1056/nejmoa1112088

Field-Weighted Citation Impact: 265.91